Xtandi 40 MG tablet 120S

Ended Awarded

Contract number
SPE2DX25F5ZTE
Awardee
Awarding agency
Obligated
$16,678

Award facts

Contract value 100% obligated
$16,678.36 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order for pharmaceutical products and medical supplies awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $16,678.36 contract covers the delivery of XTANDI 40 MG TABLET 120S to military healthcare facilities through March 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of the Department of Defense. This contract is not associated with any set-aside designation.

Quick answers

Who was awarded contract SPE2DX25F5ZTE?

SPE2DX25F5ZTE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on March 24, 2025.

How much is contract SPE2DX25F5ZTE worth?

The government has obligated $16,678 on SPE2DX25F5ZTE.

Is contract SPE2DX25F5ZTE an order under another contract?

Yes. SPE2DX25F5ZTE is a delivery order under SPE2DX15D9114, an indefinite delivery contract.

Was contract SPE2DX25F5ZTE competed?

The extent of competition for SPE2DX25F5ZTE was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award